Enhanced mitochondrial function in B cells from elderly type-2 diabetes mellitus patients supports intrinsic inflammation

Front Aging. 2024 Aug 23:5:1444527. doi: 10.3389/fragi.2024.1444527. eCollection 2024.

Abstract

In this paper, we measured B cell function in elderly healthy individuals (EH) and in elderly patients with Type-2 Diabetes Mellitus (T2DM, ET2DM), which are treatment-naive, as compared to healthy young (YH) individuals. Results show a higher serum inflammatory status of elderly versus young individuals, and especially of ET2DM versus EH. This status is associated with a reduced response to the seasonal influenza vaccine and with increased frequencies of the circulating pro-inflammatory B cell subset called Double Negative (DN) B cells. B cells from ET2DM patients are not only more inflammatory but also hyper-metabolic as compared to those from EH controls. The results herein are to our knowledge the first to show that T2DM superimposed on aging further increases systemic and B cell intrinsic inflammation, as well as dysfunctional humoral immunity. Our findings confirm and extend our previously published findings showing that inflammatory B cells are metabolically supported.

Keywords: B cells; aging; inflammation; metabolism; type-2 diabetes mellitus.

Grants and funding

The authors declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported by NIH award R56 AG059719 to DF, by CAPES Print award 88887.917362/202300 to DF, and by CAPES Print award 88881.310735/201801 to VB.